BindingDB logo
myBDB logout

null

SMILES: Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1

InChI Key: InChIKey=GJPUEPDRSRFYRD-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50246944   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone-lysine N-methyltransferase EZH2


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.48E+4n/an/an/an/an/an/a



WuXi AppTec

Curated by ChEMBL


Assay Description
Inhibition of EZH2 in human KARPAS422 cells assessed as reduction in H3K27me3 level after 72 hrs by ELISA


J Med Chem 61: 650-665 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01375
BindingDB Entry DOI: 10.7270/Q2X069G8
More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 11n/an/an/an/an/an/a



WuXi AppTec

Curated by ChEMBL


Assay Description
Inhibition of EZH2 in human KARPAS422 cells assessed as reduction in H3K27me3 level after 72 hrs by ELISA


J Med Chem 61: 650-665 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01375
BindingDB Entry DOI: 10.7270/Q2X069G8
More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
A. Compound preparation1. Prepare 10 mM stock solutions in 100% DMSO from solid material2. Serial dilute 10 mM compound stocks either 2 or 3-fold in ...


US Patent US10570121 (2020)


BindingDB Entry DOI: 10.7270/Q28W3GQD
More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2 [2-746,Y641N]


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 740n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
A. Compound preparation1. Prepare 10 mM stock solutions in 100% DMSO from solid material2. Serial dilute 10 mM compound stocks either 2 or 3-fold in ...


US Patent US10570121 (2020)


BindingDB Entry DOI: 10.7270/Q28W3GQD
More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
A. Compound preparation1. Prepare 10 mM stock solutions in 100% DMSO from solid material2. Serial dilute 10 mM compound stocks either 2 or 3-fold in ...


US Patent US10570121 (2020)


BindingDB Entry DOI: 10.7270/Q28W3GQD
More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2 [2-746,Y641N]


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
A. Compound preparation1. Prepare 10 mM stock solutions in 100% DMSO from solid material2. Serial dilute 10 mM compound stocks either 2 or 3-fold in ...


US Patent US10570121 (2020)


BindingDB Entry DOI: 10.7270/Q28W3GQD
More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 378n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
A. Compound preparation1. Prepare 10 mM stock solutions in 100% DMSO from solid material2. Serial dilute 10 mM compound stocks either 2 or 3-fold in ...


US Patent US10570121 (2020)


BindingDB Entry DOI: 10.7270/Q28W3GQD
More data for this
Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2 [2-746,Y641N]


(Homo sapiens (Human))
BDBM50246944
PNG
(CHEMBL4080606 | US10570121, Example 38)
Show SMILES Cc1cc(C)c(CN2CCc3c(Cl)cc(C(CO)C4CCOCC4)c(Cl)c3C2=O)c(=O)[nH]1
Show InChI InChI=1S/C24H28Cl2N2O4/c1-13-9-14(2)27-23(30)18(13)11-28-6-3-16-20(25)10-17(22(26)21(16)24(28)31)19(12-29)15-4-7-32-8-5-15/h9-10,15,19,29H,3-8,11-12H2,1-2H3,(H,27,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
A. Compound preparation1. Prepare 10 mM stock solutions in 100% DMSO from solid material2. Serial dilute 10 mM compound stocks either 2 or 3-fold in ...


US Patent US10570121 (2020)


BindingDB Entry DOI: 10.7270/Q28W3GQD
More data for this
Ligand-Target Pair